
Investing.com — Here is your Pro Recap of the biggest analyst cuts you may have missed since yesterday: downgrades at Eli Lilly, Simon Property Group, Wendy's, and Chipotle Mexican Grill.
InvestingPro subscribers got this news first. Never miss another market-moving headline.
Daiwa Securities downgraded Eli Lilly (NYSE:LLY) to Outperform from Buy with a price target of $610.00, as reported in real-time on InvestingPro. This price target implies a nearly 7% upside from the closing price on Wednesday.
Earlier this week, Eli Lilly announced the extension of its tender offer for acquiring all outstanding shares of POINT Biopharma Global (NASDAQ:PNT) at $12.50 per share in cash. The original deadline of Dec 15 for this offer has been extended to Dec 22. This extension allows more time to meet the minimum tender conditions necessary for the acquisition.
Morgan Stanley downgraded Simon Property Group (NYSE:SPG) to Equalweight from Overweight with a price target of $143.00 (from $132.00).
The analysts explained the downgrade by noting the significant reduction in the valuation gap between Simon Property Group and its open-air center peers. This gap has decreased from -40% to -16%.
The analysts pointed out that the consensus estimate for 2024 earnings of $12.18 per share is notably higher than Morgan Stanley's estimate of $11.88. This discrepancy could lead to 2024 guidance falling short of expectations when announced in February.
Rising interest cost limits our FFO growth to 1-2% in the next couple years vs. high quality open air center peers in the mid single digits.
Wedbush downgraded The Wendy’s (NASDAQ:WEN) to Neutral from Outperform.
Similarly, Wedbush cut Chipotle Mexican Grill's (NYSE:CMG) rating to Neutral from Outperform.
Amid whipsaw markets and a slew of critical headlines, seize on the right timing to protect your profits: Always be the first to know with InvestingPro.
Begin trading today! Create an account by completing our form
At One Financial Markets we are committed to safeguarding your privacy.
Please see our Privacy Policy for details about what information is collected from you and why it is collected. We do not sell your information or use it other than as described in the Policy.
Please note that it is in our legitimate business interest to send you certain marketing emails from time to time. However, if you would prefer not to receive these you can opt-out by ticking the box below.
Alternatively, you can use the unsubscribe link at the bottom of the Demo account confirmation email or any subsequent emails we send.
By completing the form and downloading the platform you agree with the use of your personal information as detailed in the Policy.